DK0430149T3 - Farmaceutiske præparater - Google Patents

Farmaceutiske præparater

Info

Publication number
DK0430149T3
DK0430149T3 DK90122574.8T DK90122574T DK0430149T3 DK 0430149 T3 DK0430149 T3 DK 0430149T3 DK 90122574 T DK90122574 T DK 90122574T DK 0430149 T3 DK0430149 T3 DK 0430149T3
Authority
DK
Denmark
Prior art keywords
weight
denotes
polyloxyethylene
pyrid
amounting
Prior art date
Application number
DK90122574.8T
Other languages
Danish (da)
English (en)
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Application granted granted Critical
Publication of DK0430149T3 publication Critical patent/DK0430149T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90122574.8T 1989-11-29 1990-11-26 Farmaceutiske præparater DK0430149T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
DK0430149T3 true DK0430149T3 (da) 1994-03-28

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90122574.8T DK0430149T3 (da) 1989-11-29 1990-11-26 Farmaceutiske præparater

Country Status (29)

Country Link
US (1) US5118698A (de)
EP (1) EP0430149B1 (de)
JP (1) JPH0660097B2 (de)
KR (1) KR940000066B1 (de)
CN (1) CN1035357C (de)
AT (1) ATE102051T1 (de)
AU (1) AU626480B2 (de)
BR (1) BR9006025A (de)
CA (1) CA2030911C (de)
CY (1) CY1970A (de)
CZ (1) CZ282898B6 (de)
DE (2) DE3939492A1 (de)
DK (1) DK0430149T3 (de)
EG (1) EG19557A (de)
ES (1) ES2062271T3 (de)
FI (1) FI103713B (de)
HK (1) HK216896A (de)
HU (1) HU220867B1 (de)
IE (1) IE64672B1 (de)
IL (1) IL96450A (de)
MX (1) MX23518A (de)
MY (1) MY104540A (de)
NO (1) NO180475C (de)
NZ (1) NZ236255A (de)
PT (1) PT96003B (de)
RU (1) RU2038080C1 (de)
SK (1) SK280599B6 (de)
YU (1) YU227290A (de)
ZA (1) ZA909549B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
ES2331058T3 (es) * 2001-02-28 2009-12-21 Intervet International Bv Emulsiones de agua en aceite inyectables.
AU2003210517A1 (en) 2002-02-04 2003-09-02 Elan Pharma International, Ltd. Drug nanoparticles with lysozyme surface stabiliser
EP1551457A1 (de) * 2002-07-16 2005-07-13 Elan Pharma International Limited Flüssige dosierzusammensetzungen von stabilen wirkstoffen in nanoteilchenform

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (de) * 1982-06-09 1984-10-22 Pfizer
AU4882685A (en) * 1984-10-19 1986-04-24 Schering Corporation 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4- difluorophenyl) propane

Also Published As

Publication number Publication date
CA2030911A1 (en) 1991-05-30
SK595390A3 (en) 2000-04-10
FI905814A0 (fi) 1990-11-26
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
DE69007029T2 (de) 1994-06-09
PT96003A (pt) 1991-09-13
NO180475B (no) 1997-01-20
CN1052046A (zh) 1991-06-12
EP0430149A2 (de) 1991-06-05
BR9006025A (pt) 1991-09-24
CY1970A (en) 1997-09-05
NZ236255A (en) 1992-02-25
IE904282A1 (en) 1991-06-05
NO905106L (no) 1991-05-30
DE3939492A1 (de) 1991-06-06
ZA909549B (en) 1992-06-24
IL96450A (en) 1994-10-21
US5118698A (en) 1992-06-02
HUT57039A (en) 1991-11-28
SK280599B6 (sk) 2000-04-10
ATE102051T1 (de) 1994-03-15
IE64672B1 (en) 1995-08-23
JPH0660097B2 (ja) 1994-08-10
CN1035357C (zh) 1997-07-09
HU220867B1 (en) 2002-06-29
RU2038080C1 (ru) 1995-06-27
FI905814A (fi) 1991-05-30
EG19557A (en) 1997-08-31
ES2062271T3 (es) 1994-12-16
NO180475C (no) 1997-04-30
NO905106D0 (no) 1990-11-26
JPH03176421A (ja) 1991-07-31
YU227290A (sh) 1993-10-20
CZ282898B6 (cs) 1997-11-12
EP0430149A3 (en) 1991-09-25
KR940000066B1 (ko) 1994-01-05
EP0430149B1 (de) 1994-03-02
HK216896A (en) 1996-12-27
AU6706590A (en) 1991-08-08
FI103713B (fi) 1999-08-31
MX23518A (es) 1993-04-01
KR910009286A (ko) 1991-06-28
CZ595390A3 (en) 1997-06-11
AU626480B2 (en) 1992-07-30
MY104540A (en) 1994-04-30
PT96003B (pt) 1998-01-30
CA2030911C (en) 1995-02-07

Similar Documents

Publication Publication Date Title
ATE68180T1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
FI950016A (fi) Heterosykliset yhdisteet lääkeaineena
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE110076T1 (de) Verbindungen der 1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure.
FI881816A (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
DK0430149T3 (da) Farmaceutiske præparater
DK451389A (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
MX9206930A (es) Nuevos compuestos
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
DE69130266T2 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
ATE168995T1 (de) N-(mercaptoacyl)aminosäure, ihre herstellung, ihre therapeutische verwendung und sie enthaltende pharmazeutische zusammensetzungen
SE9402596L (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
ATE87004T1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.
KR890013001A (ko) 자극성 아미노산 수용체 길항제인 테트라졸 유도체